TMCI — Treace Medical Concepts Balance Sheet
0.000.00%
- $422.62m
- $400.25m
- $209.36m
- 81
- 32
- 93
- 78
Annual balance sheet for Treace Medical Concepts, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 18.1 | 106 | 81.3 | 123 | 75.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.5 | 18.6 | 29.2 | 38.1 | 40.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 41 | 138 | 133 | 198 | 161 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.829 | 2.85 | 25.5 | 31.6 | 34.4 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 41.8 | 141 | 159 | 252 | 217 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11.6 | 18.2 | 30.2 | 45 | 34.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 41 | 47.7 | 98.5 | 114 | 104 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 0.776 | 93.1 | 60.5 | 138 | 113 |
Total Liabilities & Shareholders' Equity | 41.8 | 141 | 159 | 252 | 217 |
Total Common Shares Outstanding |